CalChem Synthesis

CalChem Synthesis

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CalChem Synthesis is a private, revenue-generating contract research organization (CRO) focused on providing custom synthetic chemistry and process R&D services to biotech, pharmaceutical, and research institutions. Leveraging over 35 years of combined industry experience from its leadership team, the company executes projects from milligram to kilogram scale, supporting clients from early discovery through preclinical development. As a service provider, it operates in a competitive CRO landscape, differentiating itself through deep expertise in organic synthesis and a client-centric approach to project management.

Small MoleculesDrug Delivery

Technology Platform

Expertise-driven synthetic organic chemistry services, including custom synthesis, route scouting, process R&D, and scale-up from milligram to kilogram scale.

Opportunities

The growing trend of pharmaceutical and biotech companies outsourcing early-stage R&D creates sustained demand for specialized chemistry CROs.
Expansion into adjacent service areas, such as early GMP manufacturing or supporting novel drug modalities, could provide avenues for growth.

Risk Factors

Revenue is highly dependent on the funding and R&D spending cycles of the biotech sector, creating potential volatility.
The company operates in a very competitive CRO market and is reliant on its key personnel and reputation for successful project execution.

Competitive Landscape

CalChem competes in the fragmented chemistry CRO market against large global players (e.g., LabCorp, Charles River), specialized synthetic chemistry firms, and academic core facilities. Its differentiation is based on deep Ph.D.-level expertise, a client-centric approach, and the specific industry experience of its founder from established CROs like AMRI.